text: <unk>  is a bronchodilator that is FDA approved for the treatment of adjunct to inhaled beta-2 selective agonists and systemically administered corticosteroids for the treatment of acute exacerbations of the symptoms and reversible airflow obstruction associated with asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis.   Common adverse reactions include severe allergic reactions of the skin, including exfoliative dermatitis.
option_0: Aminophylline
option_1: Theophylline
option_2: Tiotropium
option_3: Albuterol
option_4: Methacholine
option_5: Levosalbutamol
option_6: Tulobuterol
option_7: Levalbuterol